Kuvacić I, Skrablin S, Drazancić A, Fudurić I, Hodzić D
Klinika za zenske bolesti i porode u Zagrebu.
Jugosl Ginekol Perinatol. 1990 Sep-Dec;30(5-6):143-7.
The outcome of stimulation of labour in 219 primiparous patients with more than 6 hours following a premature rupture of the membranes, and with an ripe cervix, without the established labour, was analysed according to the mode of treatment. One hundred and thirty eight (138) women received PGE2 peroral tablets, 14 intracervical PGE2 gel, and 67 oxytocin intravenously. There were 73.2% vaginal deliveries in the group that received PGE2 per os, 77.5% in the group that received oxytocin, and 92.9% in the group that was given intracervical gel. The differences were significant. The cervix remained unripe in 9.4% patients that received PGE2 perorally, in 14.9% of those that received oxytocin, while in the gel group it became favourable in all parturients. Uterine polisistoly was encountered in 10.9% labours after peroral stimulation, in 7.1% in the gel group and in 1.5% in the oxytocin group, and perinatal asphyxia in 16.7%, 7.1% and 13.4%, respectively. When too frequent, especially if combined with oxytocin and given to patients with a moderately favourable cervix, peroral stimulation predisposes to uterine polisitoly. Intracervical application of PGE2 gel is the method of choice in primigravid patients with a premature rupture of the membranes and the unripe cervix (Bishop score O). In gravidas with a more favourable cervix (Bishop score 4-6) the administration of oxytocin is acceptable with less complications. In those with a moderately favourable cervix (Bishop score 1-4) the gel application proved to be preferable, although stimulation could be carried out as well.
对219例初产妇在胎膜早破6小时以上、宫颈成熟但未临产的情况下引产的结果,根据治疗方式进行了分析。138名妇女口服PGE2片剂,14名宫颈内给予PGE2凝胶,67名静脉滴注缩宫素。口服PGE2组阴道分娩率为73.2%,缩宫素组为77.5%,宫颈内给予凝胶组为92.9%。差异具有统计学意义。口服PGE2的患者中9.4%宫颈仍未成熟,接受缩宫素的患者中14.9%宫颈未成熟,而凝胶组所有产妇宫颈均转为有利。口服刺激后10.9%的分娩出现子宫收缩过强,凝胶组为7.1%,缩宫素组为1.5%,围产期窒息率分别为16.7%、7.1%和13.4%。口服刺激过于频繁时,尤其是与缩宫素联合应用于宫颈条件中等有利的患者时,易导致子宫收缩过强。对于胎膜早破且宫颈未成熟(Bishop评分0)的初产妇,宫颈内应用PGE2凝胶是首选方法。对于宫颈条件更有利(Bishop评分4 - 6)的孕妇,应用缩宫素并发症较少是可以接受的。对于宫颈条件中等有利(Bishop评分1 - 4)的孕妇,尽管也可进行刺激,但应用凝胶被证明更可取。